This firm's average rating is Strong Buy from 5 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on NuCana Plc market sentiment investors' perception of the future value of NuCana. Let us look at a few aspects of NuCana technical analysis.
Using predictive
technical analysis, we can analyze different prices and returns patterns and
diagnose historical swings to determine the real value of NuCana PLC. In general, sophisticated investors focus on analyzing NuCana PLC stock price patterns and their correlations with different microeconomic environment and drivers. They apply predictive analytics to build NuCana PLC's daily price indicators and compare them against related drivers such as
momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional
technical analysis and
fundamental analysis, we attempt to find the most accurate representation of
NuCana PLC's intrinsic value. In addition to deriving basic predictive indicators for NuCana PLC, many experienced traders also check how macroeconomic factors affect NuCana PLC price patterns. Please read more on our
technical analysis page or use our predictive modules below to complement your research.
Watch out for price decline
Please consider monitoring NuCana PLC on a daily basis if you are holding a position in it. NuCana PLC is trading at a penny-stock level, and the possibility of delisting is much higher compared to other stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion.
Most exchanges require public instruments, such as NuCana PLC stock to be traded above the $1 level to remain listed. If NuCana PLC stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.
How does NuCana Stands against Peers?
Analyzing NuCana PLC competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to NuCana PLC across multiple sectors and
thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be. Check out
NuCana PLC Competition DetailsNuCana PLC Gross Profit
NuCana PLC Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing NuCana PLC previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show NuCana PLC Gross Profit growth over the last 10 years. Please check NuCana PLC's
gross profit and other
fundamental indicators for more details.
Closer look at NuCana Plc Mean Deviation
NuCana Plc has current Mean Deviation of 2.86. The mean deviation of the equity instrument is the first measure of the distances between each value of security historical prices and the mean. It gives us an idea of how spread out from the center the distribution of returns.
Mean Deviation is the average of the absolute values of the differences between price distribution numbers and their mean. Mean deviation of equity instrument with a lot of historical data is a biased estimator because the time horizon used in calculation will always be much smaller than the entire price history of the equity. The mean deviation is typically used as a measure of dispersion for small investment horizon, otherwise standard deviation is a better measure of dispersion.
Mean Deviation | = | SUM(RET DEV) N |
| = | 2.86 |
| SUM | = | Summation notation |
| RET DEV | = | Sum of return deviations of NuCana Plc |
| N | = | Number of calculation points for selected time horizon |
Let's now compare NuCana Plc Mean Deviation to its closest peers:
| NCNA | 2.8599741542699713 |
| DYAI | 3.79 |
| DRNA | 3.75 |
| DMAC | 5.05 |
| EQ | 22.53 |
Over 3 percent build-up for NuCana Plc. What does it mean for investors?
Current Jensen Alpha is up to -0.01. Price may slip again. NuCana Plc shows above-average downside volatility for the selected time horizon. We advise investors to inspect NuCana Plc further and ensure that all market timing and asset allocation strategies are consistent with the estimation of NuCana Plc future alpha.
Our Conclusion on NuCana Plc
Whereas some firms within the biotechnology industry are still a little expensive, even after the recent corrections, NuCana Plc may offer a potential longer-term growth to investors. To conclude, as of the 25th of July 2020, our analysis shows that NuCana Plc almost mirrors the market. The company is
undervalued and projects
close to average chance of distress for the next 2 years. Our latest 30 days 'Buy-vs-Sell' recommendation on the company is
Cautious Hold.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of NuCana PLC. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com